Segment Information (Segment Results) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2013	Sep. 27, 2013	Jun. 28, 2013	Mar. 29, 2013	Dec. 31, 2012	Sep. 28, 2012	Jun. 29, 2012	Mar. 30, 2012	Dec. 31, 2013 Reporting_Unit	Dec. 31, 2012 Reporting_Unit	Dec. 31, 2011 Reporting_Unit
Number of segments									5	5	5
Sales	$ 5,266.7	$ 4,669.1	$ 4,737.5	$ 4,444.7	$ 4,975.2	$ 4,415.5	$ 4,553.5	$ 4,316.2	$ 19,118.0	$ 18,260.4	$ 16,090.5
Operating profit:	888.0	812.4	843.6	730.9	863.1	755.8	811.3	734.9	3,274.9	3,165.1	2,617.2
Identifiable assets (including assets held for sale):	34,672.2				32,941.0				34,672.2	32,941.0	29,949.5
Depreciation and amortization:									895.0	839.8	635.0
Capital expenditures, gross:									551.5	458.3	334.5
Test & Measurement
Sales									3,417.3	3,381.0	3,390.9
Operating profit:									669.5	701.2	751.2
Identifiable assets (including assets held for sale):	5,495.0				5,505.8				5,495.0	5,505.8	5,280.6
Depreciation and amortization:									135.1	132.3	126.6
Capital expenditures, gross:									38.8	37.5	37.7
Environmental
Sales									3,316.9	3,063.5	2,939.6
Operating profit:									696.5	652.5	622.7
Identifiable assets (including assets held for sale):	3,584.5				3,146.6				3,584.5	3,146.6	2,784.8
Depreciation and amortization:									62.7	48.9	45.9
Capital expenditures, gross:									46.5	29.5	29.1
Life Sciences & Diagnostics
Sales									6,856.4	6,485.1	4,627.4
Operating profit:									1,009.8	861.1	402.3
Identifiable assets (including assets held for sale):	13,614.7				13,305.2				13,614.7	13,305.2	12,888.4
Depreciation and amortization:									517.3	478.2	297.2
Capital expenditures, gross:									386.7	296.8	167.0
Dental
Sales									2,094.9	2,022.9	2,011.2
Operating profit:									304.9	293.1	236.1
Identifiable assets (including assets held for sale):	4,095.1				4,079.9				4,095.1	4,079.9	4,047.5
Depreciation and amortization:									83.3	92.4	94.0
Capital expenditures, gross:									30.7	30.2	35.4
Industrial Technologies
Sales									3,432.5	3,307.9	3,121.4
Operating profit:									722.9	685.6	655.0
Identifiable assets (including assets held for sale):	4,363.6				4,235.6				4,363.6	4,235.6	3,394.9
Depreciation and amortization:									89.2	80.8	65.8
Capital expenditures, gross:									47.1	49.0	51.3
Equity method earnings related to Apex joint venture
Operating profit:									0	69.9	66.8
Other
Operating profit:									(128.7)	(98.3)	(116.9)
Identifiable assets (including assets held for sale):	3,519.3				2,667.9				3,519.3	2,667.9	1,553.3
Depreciation and amortization:									7.4	7.2	5.5
Capital expenditures, gross:									$ 1.7	$ 15.3	$ 14.0